Please login to the form below

Not currently logged in

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.

Latest news

More from news
Approximately 13 fully matching, plus 353 partially matching documents found.

Latest Intelligence

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.

  • BRIC markets BRIC markets

    The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.

  • The mission matters The mission matters

    Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    the US market when they would, de facto, be barred from other developed and price-controlled markets. ... As emerging markets become richer, access to at least basic healthcare is one of the first developed market characteristics that their citizens seek

More from intelligence
Approximately 14 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • Syndicated study

    Maximising digital communications with physicians in China. We are currently conducting a syndicated study to assess the impact of COVID-19 on how Chinese doctors use digital channels to interact with pharma companies through interviews with 270

  • Article: Spotlight on Mexico

    Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican

  • News: Mandira Kar joins London Headquarters as Qualitative Research Director

    She has previously worked in a wide range of research industries including consumer and digital and has experience in many global markets, especially emerging markets, having lived and worked for a

  • Article: Market access in Brazil

    All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? In April 2019, Brazilian Health Minister Luiz Henrique

  • China: How to strategise and win in the world's fastest changing healthcare market

    In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region. Download

More from PMHub
Approximately 67 fully matching, plus 39 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...